Oragenics Announces Closing of $6.0 Million Underwritten Public Offering
Oragenics Announces Closing of $6.0 Million Underwritten Public Offering
Business Wire · 11/24 16:37
Mid-Afternoon Market Update: Dow Drops Over 100 Points; Mesoblast Shares Spike Higher
Toward the end of trading Friday, the Dow traded down 0.46% to 29,346.95 while the NASDAQ rose 0.14% to 11,920.95. The S&P also fell, dropping 0.20% to 3,574.82.
Benzinga · 11/20 19:32
Mid-Day Market Update: Nasdaq Edges Higher; Nano Dimension Shares Plunge
Midway through trading Friday, the Dow traded down 0.43% to 29,355.69 while the NASDAQ rose 0.14% to 11,921.21. The S&P also fell, dropping 0.24% to 3,573.32.
Benzinga · 11/20 17:37
Oragenics shares drop 28% after pricing $5.25M stock offering
Oragenics (OGEN) plunges 28% premarket after pricing its public offering of ~14.2M common shares at $0.37/share, for expected gross proceeds of ~$5.25M.Underwriters' over-allotment is an additional 2,128,378 shares. Net proceeds will be used
Seekingalpha · 11/20 13:42
Oragenics Prices $5.25M Offering Of 14.189M Shares At $0.37/Share
Oragenics Prices $5.25 Million Common Stock Offering Oragenics, Inc. (NYSE:OGEN) ("Oragenics" or the "Company"), a company focused on the creation of the Terra CoV-2 vaccine candidate to combat
Benzinga · 11/20 13:32
Oragenics Prices $5.25 Million Common Stock Offering
ORAGENICS PRICES $5.25 MILLION COMMON STOCK OFFERING
Business Wire · 11/20 13:30
CORRECTING AND REPLACING Oragenics Announces Proposed Underwritten Public Offering
Oragenics Announces Proposed Underwritten Public Offering
Business Wire · 11/19 22:14
Oragenics launches equity offering
Oragenics (OGEN) down 1% AH, has commenced a proposed underwritten public offering of common stock.Volume, price are yet to be determined.
Seekingalpha · 11/19 21:27
Why Oragenics Stock Is Trading Higher Today
Oragenics (NYSE: OGEN) shares are trading higher on Tuesday after the company announced the FDA broadly supports its pre-IND development program for its SARS-CoV-2 vaccine.
Benzinga · 10/06 14:35
Benzinga Pro's Top 5 Stocks To Watch For Tuesday, Oct. 6, 2020: DPZ, AZYO, OGEN, ALKS, AN
Today's 5 Stock Ideas: Domino’s Pizza (DPZ) - Will report Q3 earnings before market open on Thursday. Analysts expect EPS of $2.71 on revenue of $943.77 million. Aziyo Biologics
Benzinga · 10/06 12:10
FDA backs Oragenics' Pre-IND development program for SARS-CoV-2 vaccine
Oragenics (OGEN) jumps 19% premarket after receiving feedback to Type B Pre-IND Meeting Request from the FDA that the Agency is in broad agreement with the Company’s clinical development program for its SARS-CoV-2
Seekingalpha · 10/06 11:41
FDA Broadly Supports Oragenics' Pre-IND Development Program for its SARS-CoV-2 Vaccine; Re-Affirms Plan to File IND Application by the End of 1Q21, Begin Phase 1 Study in Early 2Q21
TAMPA, Fla.--(BUSINESS WIRE)-- Oragenics, Inc. (NYSE:OGEN) (“Oragenics” or the “Company”) announced receipt of feedback to its Type B Pre-IND Meeting Request from the U.S. Food and Drug
Benzinga · 10/06 11:31
Oragenics comes up empty in pursuit BARDA funding for COVID-19 vaccine
Nano cap Oragenics (OGEN) reports that the U.S. Health and Human Services' Biomedical Advanced Research and Development Authority ((BARDA)) has decided to pass on funding the development of COVID-19 vaccine
Seekingalpha · 09/28 11:48
Oragenics Says Has Been Informed Of BARDA's Determination Not To Enter Negotiation With Co.; Says 'a combination of factors, including availability of funds, precluded the agency from entering into negotiations at this time.'
Oragenics, Inc. (NYSE:OGEN) ("Oragenics" or the "Company") provides an update on U.S. federal government and other funding options the Company is pursuing in order to advance its SARS-CoV-2
Benzinga · 09/28 11:32
Oragenics Inc. to Present at the H.C. Wainwright 22nd Annual Global Virtual Investment Conference
Oragenics Inc. to Present at the H.C. Wainwright 22nd Annual Global Virtual Investment Conference
Business Wire · 09/11 11:30
OGEN: SARS-CoV-2 Vaccine to Enter the Clinic in Early 2021
By David Bautz, PhD NYSE:OGEN READ THE FULL OGEN RESEARCH REPORT Business Update Developing Vaccine Against SARS-CoV-2 In May 2020, Oragenics, Inc. (NYSE:OGEN) announced the acquisition of Noachis Terra Inc., which is developing TerraCoV2, a vaccine candidate against SARS-CoV-2 (the virus that causes
Zacks Small Cap Research · 09/03 14:47
Oragenics Signs Process Development and Manufacturing Agreement With Avid Bioservices for Coronavirus Vaccine
Business Wire · 08/20 13:30
Oragenics inks deal with Avid Bio for advancement of COVID-19 vaccine
Oragenics (OGEN) soars 24% premarket after entering into a process development and drug substance manufacturing agreement with Avid Bioservices (CDMO), up 5%.Under terms of the agreement, Avid will provide Oragenics with analytical method
Seekingalpha · 08/20 12:59
Ocugen and vTv Therapeutics among healthcare gainers; Vaxart leads the losers
Seeking Alpha · 07/27 15:02
INTC, NIO among premarket losers
Seeking Alpha - Article · 07/24 12:24
Webull provides a variety of real-time OGEN stock news. You can receive the latest news about ORAGENICS through multiple platforms. This information may help you make smarter investment decisions.